Sandra Kim, MD
Additional Locations
Pediatric Gastroenterology, Hepatology, and Nutrition
Medina Hospital Medical Office Building
970 East Washington Street
Medina, OH 44256
Driving Directions
- Appointment:
- 216.444.8950
- Desk:
- 216.445.9350
- Fax:
- 216.444.2974
Treatment & Services
- Blood Tests
- Center for Pediatric Gastroenterology
- Dietary Management for IBD in Children and Adults
- EGD
- Evaluation for Caustic Ingestion
- Foreign Body Removal
- Outpatient Care
- Polypectomy
- Screening and Testing
- Therapeutic Endoscopy
- Wireless Capsule Endoscopy
Specialty in Diseases & Conditions
- Abdominal Pain
- Celiac Disease (Celiac Sprue)
- Crohn's Disease
- Diarrhea
- Eosinophilic Esophagitis
- Eosinophilic Gastroenteritis
- Failure to Thrive
- Gastroesophageal Reflux (GERD)
- GI Bleeding
- Inflammatory Bowel Disease (IBD)
- Irritable Bowel Syndrome (IBS)
- Ulcerative Colitis
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Sandra Kim, MD
Sandra Kim, MD, a nationally recognized expert in pediatric and adolescent inflammatory bowel disease, is the chair of Pediatric Gastroenterology, Hepatology and Nutrition. Prior to this, she was Director of the Inflammatory Bowel Disease (IBD) Center within the Division of Pediatric Gastroenterology, Hepatology, and Nutrition at UPMC Children’s Hospital of Pittsburgh.
Dr. Kim is a graduate of the University of Michigan’s Inteflex (Integrated Pre-medical/Medical) Program, earning bachelor’s degrees in Biomedical Sciences and Psychology as well as her medical degree.
Dr. Kim’s clinical and research interests focus on pediatric inflammatory bowel diseases, including adolescent transitioning and quality improvement in pediatric IBD, advocacy for care access, and the impact of the gastrointestinal microbiota in IBD. As a reflection of her dedication to her profession, Dr. Kim was awarded the 2011 and 2018 Rosenthal Awards and a 2020 Uniting to Care and Cure Award for her leadership in patient education and advocacy by the Crohn’s and Colitis Foundation.
She currently serves on the Board of Directors for Improve Care Now (ICN), a national pediatric IBD quality improvement network. She is the current co-chair of the DEI committee and a member of the Community Council for ICN. She is also a member of the Medical Advisory Board, Flying Horse Farms.
Dr. Kim has been an active member of the Crohn’s and Colitis Foundation over the past 25 years. She was a past chair for the Government Affairs and Pediatric Affairs committees for the Foundation’s National Scientific Advisory Committee (NSAC) and has remained involved in the Foundation - funded pediatric research network, PROKIIDS. She was on the Board of Directors for the Central Ohio chapter of the Foundation and recently completed her term as board president for the Western Pennsylvania/West Virginia chapter of the Foundation (2021-2022). She currently is a member of the Northern Ohio Chapter Board of Directors for the Foundation.
Education & Professional Highlights
Appointed
2023
Education & Fellowships
Fellowship - Baylor College of Medicine
Pediatric Gastroenterology
Houston,
TX USA
2000
Residency - Baylor College of Medicine
Pediatrics
Houston,
TX USA
1997
Medical Education - University of Michigan Medical School (Ann Arbor)
Ann Arbor,
MI USA
1994
Undergraduate - University of Michigan
Biomedical Sciences/Psychology
Ann Arbor,
MI USA
1991
Certifications
- Pediatrics - Pediatric Gastroenterology
- Pediatrics
Awards & Honors
- Rosenthal Award (Crohn's and Colitis Foundation): 2011 and 2018
- Uniting to Care and Cure Award (Crohn's and Colitis Foundation): 2020
Research & Publications
See publications for Sandra Kim, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/18/2023, Dr. Kim has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
